51160 Federal Register / Vol. 86, No. 175 / Tuesday, September 14, 2021 / Notices 

the introduction of influenza infection 

to households that have school-age 

children, as well as within-household 

influenza transmission. 

CDC requests approval for 434 annual 

burden hours. There is no cost to 

respondents other than their time to 

participate. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Form name Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Parents of children/adolescents or adult students (≥18 yo) attending schools.Screening Form .............................................. 345 1 5/60 

Acute Respiratory Infection and Influenza 

Surveillance Form.

300 1 15/60 

Household Study Form A ............................... 300 1 5/60 

Student ............................................................ Biospecimen collection (Day 0) ..................... 300 1 5/60 

Parents of children/adolescents or adult students (≥18 yo) attending schools.Household Study Form B (Day 7 and 14) ..... 240 1 5/60 

Student ............................................................ Biospecimen collection (Day 7 and 14) ......... 240 1 5/60 

Household members ....................................... Household Study Form B (Day 0, 7 and 14) 720 2 5/60 

Household members ....................................... Biospecimen collection (Day 0, 7 and 14) ..... 720 2 5/60 

Jeffrey M. Zirger, 

Lead, Information Collection Review Office, 

Office of Scientific Integrity, Office of Science, 

Centers for Disease Control and Prevention. 

[FR Doc. 2021–19754 Filed 9–13–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Biodefense Science Board 

AGENCY: Office of the Assistant 

Secretary for Preparedness and 

Response (ASPR), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The National Biodefense 

Science Board (NBSB or the Board) is 

authorized under Section 319M of the 

Public Health Service (PHS) Act, as 

added by Section 402 of the Pandemic 

and All-Hazards Preparedness Act of 

2006 and amended by Section 404 of the 

Pandemic and All-Hazards 

Preparedness Reauthorization Act. The 

Board is governed by the Federal 

Advisory Committee Act, which sets 

forth standards for the formation and 

use of advisory committees. The NBSB 

provides expert advice and guidance on 

scientific, technical, and other matters 

of special interest to the Department 

regarding current and future chemical, 

biological, nuclear, and radiological 

agents, whether naturally occurring, 

accidental, or deliberate. 

DATES: The NBSB will meet in public 

(virtually) on September 28, 2021, to 

discuss high priority issues related to 

national public health emergency 

preparedness and response. A more 

detailed agenda will be available on the 

NBSB meeting website https://

www.phe.gov/nbsb. 

ADDRESSES: Members of the public may 

attend the meeting via a toll-free phone 

number or Zoom teleconference, which 

requires pre-registration. The meeting 

link to pre-register will be posted on 

https://www.phe.gov/nbsb. Members of 

the public may provide written 

comments or submit questions for 

consideration by the NBSB at any time 

via email to NBSB@hhs.gov. Members of 

the public are also encouraged to 

provide comments after the meeting. 

FOR FURTHER INFORMATION CONTACT: 

CAPT Christopher L. Perdue, MD, MPH, 

NBSB Designated Federal Officer, 

Washington, DC, Office, 202–401–5837, 

NBSB@hhs.gov. 

SUPPLEMENTARY INFORMATION: The NBSB 

invites those who are involved in or 

represent a relevant industry, academia, 

health profession, health care consumer 

organization, or state, Tribal, territorial 

or local government to request up to 

seven minutes to address the board in 

person via Zoom. Requests to provide 

remarks to the NBSB during the public 

meeting must be sent to NBSB@hhs.gov 

at least 15 days prior to the meeting 

along with a brief description of the 

topic. We would specifically like to 

request inputs from the public on 

challenges, opportunities, and strategic 

priorities for national health security 

and biodefense. Presenters who are 

selected for the public meeting will 

have audio only during the meeting. 

Slides, documents, and other 

presentation material sent along with 

the request to speak will be provided to 

the board members separately. Please 

indicate additionally whether the 

presenter will be willing to take 

questions from the board members (at 

their discretion) immediately following 

their presentation (for up to seven 

additional minutes). 

Dawn O’Connell, 

Assistant Secretary for Preparedness and 

Response. 

[FR Doc. 2021–19789 Filed 9–13–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Office of the Secretary 

Ninth Amendment to Declaration 

Under the Public Readiness and 

Emergency Preparedness Act for 

Medical Countermeasures Against 

COVID–19 

ACTION: Notice of amendment. 

SUMMARY: The Secretary issues this 

amendment pursuant to section 319F–3 

of the Public Health Service Act to 

expand the authority for certain 

Qualified Persons authorized to 

prescribe, dispense, and administer 

COVID–19 therapeutics that are covered 

countermeasures under section VI of 

this Declaration. 

DATE: This amendment is effective as of 

September 14, 2021. 

FOR FURTHER INFORMATION CONTACT: L. 

Paige Ezernack, Office of the Assistant 

Secretary for Preparedness and 

Response, Office of the Secretary, 

Department of Health and Human 

Services, 200 Independence Avenue 

SW, Washington, DC 20201; 202–260– 

0365, paige.ezernack@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Public Readiness and Emergency 

Preparedness Act (PREP Act) authorizes 


tkelley on DSK125TN23PROD with NOTICES